Phosphoenolpyruvate Carboxykinase (PCK) in the Brain Gluconeogenic Pathway Contributes to Oxidative and Lactic Injury After Stroke
Abstract To demonstrate the role of the rate-limiting and ATP-dependent gluconeogenic enzyme phosphoenolpyruvate carboxykinase (PCK) in oxidative and lactic stress and the effect of phenothiazine on PCK after stroke, a total of 168 adult male Sprague Dawley rats (3 months old, 280–300 g) underwent 2-h intraluminal middle cerebral artery occlusion (MCAO) and reperfusion for 6, 24, 48 h, or 7 days. Phenothiazine (chlorpromazine and promethazine (C+P)) (8 mg/kg) and 3-mercaptopicolinic acid (3-MPA, a PCK inhibitor, 100 μM) were administered at reperfusion onset. The effects of phosphoenolpyruvate, 3-MPA, or PCK knockdown were studied in neuronal cultures subjected to oxygen/glucose deprivation. Reactive oxygen species, lactate, phosphoenolpyruvate (PEP; a gluconeogenic product), mRNA, and protein of total PCK, PCK-1, and PCK-2 increased after MCAO and oxygen–glucose deprivation (OGD). Oxaloacetate (a gluconeogenic substrate) decreased, while PEP and glucose were increased, suggesting reactive gluconeogenesis. These changes were attenuated by phenothiazine, 3-MPA, or PCK shRNA. PCK-1 and -2 existed primarily in neurons, while the effects of ischemic stroke on the PCK expression were seen predominately in astrocytes. Thus, phenothiazine reduced infarction and oxidative/lactic stress by inhibiting PCKs, leading to functional recovery..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:58 |
|---|---|
| Enthalten in: |
Molecular neurobiology - 58(2021), 5 vom: 08. Jan., Seite 2309-2321 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Geng, Xiaokun [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| BKL: | |
|---|---|
| Themen: |
Gluconeogenesis |
| doi: |
10.1007/s12035-020-02251-3 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR043684092 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR043684092 | ||
| 003 | DE-627 | ||
| 005 | 20230519141339.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210403s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s12035-020-02251-3 |2 doi | |
| 035 | |a (DE-627)SPR043684092 | ||
| 035 | |a (DE-599)SPRs12035-020-02251-3-e | ||
| 035 | |a (SPR)s12035-020-02251-3-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |a 570 |q ASE |
| 084 | |a 44.90 |2 bkl | ||
| 100 | 1 | |a Geng, Xiaokun |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Phosphoenolpyruvate Carboxykinase (PCK) in the Brain Gluconeogenic Pathway Contributes to Oxidative and Lactic Injury After Stroke |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract To demonstrate the role of the rate-limiting and ATP-dependent gluconeogenic enzyme phosphoenolpyruvate carboxykinase (PCK) in oxidative and lactic stress and the effect of phenothiazine on PCK after stroke, a total of 168 adult male Sprague Dawley rats (3 months old, 280–300 g) underwent 2-h intraluminal middle cerebral artery occlusion (MCAO) and reperfusion for 6, 24, 48 h, or 7 days. Phenothiazine (chlorpromazine and promethazine (C+P)) (8 mg/kg) and 3-mercaptopicolinic acid (3-MPA, a PCK inhibitor, 100 μM) were administered at reperfusion onset. The effects of phosphoenolpyruvate, 3-MPA, or PCK knockdown were studied in neuronal cultures subjected to oxygen/glucose deprivation. Reactive oxygen species, lactate, phosphoenolpyruvate (PEP; a gluconeogenic product), mRNA, and protein of total PCK, PCK-1, and PCK-2 increased after MCAO and oxygen–glucose deprivation (OGD). Oxaloacetate (a gluconeogenic substrate) decreased, while PEP and glucose were increased, suggesting reactive gluconeogenesis. These changes were attenuated by phenothiazine, 3-MPA, or PCK shRNA. PCK-1 and -2 existed primarily in neurons, while the effects of ischemic stroke on the PCK expression were seen predominately in astrocytes. Thus, phenothiazine reduced infarction and oxidative/lactic stress by inhibiting PCKs, leading to functional recovery. | ||
| 650 | 4 | |a Gluconeogenesis |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Ischemia/reperfusion |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Neuroprotection |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Phenothiazine (promethazine, chlorpromazine, C+P) |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Shen, Jiamei |e verfasserin |4 aut | |
| 700 | 1 | |a Li, Fengwu |e verfasserin |4 aut | |
| 700 | 1 | |a Yip, James |e verfasserin |4 aut | |
| 700 | 1 | |a Guan, Longfei |e verfasserin |4 aut | |
| 700 | 1 | |a Rajah, Gary |e verfasserin |4 aut | |
| 700 | 1 | |a Peng, Changya |e verfasserin |4 aut | |
| 700 | 1 | |a DeGracia, Donald |e verfasserin |4 aut | |
| 700 | 1 | |a Ding, Yuchuan |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Molecular neurobiology |d Totowa, NJ : Humana Press, 1987 |g 58(2021), 5 vom: 08. Jan., Seite 2309-2321 |w (DE-627)SPR023948140 |w (DE-600)2079384-4 |x 1559-1182 |7 nnns |
| 773 | 1 | 8 | |g volume:58 |g year:2021 |g number:5 |g day:08 |g month:01 |g pages:2309-2321 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s12035-020-02251-3 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 44.90 |q ASE |
| 951 | |a AR | ||
| 952 | |d 58 |j 2021 |e 5 |b 08 |c 01 |h 2309-2321 | ||